Verona Pharma plc (VRNA)

Verona Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-81.19	-173.42	-54.37	-68.7	-55.57	-65.15
Depreciation & Amortization	1.11	1.06	0.68	0.64	0.63	0.62
Other Amortization	2.37	1.3	0.12	0.08	0.11	0.01
Asset Writedown & Restructuring Costs	-	-	-	-	-	0.29
Stock-Based Compensation	93.68	41.24	19.01	14.12	25.43	22.18
Other Operating Activities	9.87	13.35	-1.76	4.74	-17.3	-0.92
Change in Accounts Receivable	-82.86	-31.5	-	-	-	-
Change in Inventory	-14.52	-8.22	-	-	-	-
Change in Accounts Payable	-0.72	7.87	0.49	-7.15	9.87	-1.4
Change in Income Taxes	-1.87	14.68	-2.14	4.1	-6.78	0.77
Change in Other Net Operating Assets	1.63	11.43	-12.24	-7.69	10.36	-1.48
Operating Cash Flow	-72.49	-122.2	-50.22	-59.86	-33.25	-45.08
Capital Expenditures	-1.07	-0.58	-	-0.03	-0.01	-0.08
Investment in Securities	-	-	-	-	-	9.79
Investing Cash Flow	-1.07	-0.58	-	-0.03	-0.01	9.71
Long-Term Debt Issued	-	122.5	38.71	10	-	5
Long-Term Debt Repaid	-	-52.26	-	-5.85	-	-
Net Debt Issued (Repaid)	122.5	70.24	38.71	4.15	-	5
Issuance of Common Stock	112.2	102.9	58.86	151.17	0.73	200.2
Repurchase of Common Stock	-124.61	-15.45	-4.69	-4.72	-6.85	-
Other Financing Activities	-4.61	93.09	-0.01	-9.78	-	-12.86
Financing Cash Flow	105.47	250.78	92.87	140.82	-6.12	192.34
Foreign Exchange Rate Adjustments	1.51	-0.01	1.3	-1.48	-0.22	0.58
Net Cash Flow	33.42	127.99	43.95	79.45	-39.61	157.56
Free Cash Flow	-73.56	-122.78	-50.22	-59.89	-33.27	-45.16
Free Cash Flow Margin	-33.18%	-290.41%	-	-13076.64%	-83.17%	-
Free Cash Flow Per Share	-0.88	-1.51	-0.63	-0.91	-0.56	-1.37
Cash Interest Paid	24.71	10.33	2.01	0.35	0.22	0.01
Cash Income Tax Paid	9.82	0.64	1.25	0.12	0	0.01
Levered Free Cash Flow	-57.39	-68.93	-36.63	-34.75	2.1	-18.4
Unlevered Free Cash Flow	-36.5	-55.52	-35.46	-34.5	2.19	-18.39
Change in Net Working Capital	96.23	2.52	13.61	7.91	-12.2	-0.15

Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q